Catalyst
Slingshot members are tracking this event:
Opko (OPK) to initiate Phase 2 trial for RAYALDEE for Stage 5 CKD patients with SHPT during second Q4 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| OPK |
|
|
Vifor Fresenius |
|
|
|
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 04, 2018
Occurred Source:
http://investor.opko.com/news-releases/news-release-details/opko-initiates-rayaldee-phase-2-trial-dialysis-patients
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Rayaldee, Stage 5 Ckd, Shpt, Phase 2
